Fundamentals might be unchanged but guidance has. During the peak hype last year Daybue was being spoken about as making 1 billion in sales this year. it hasn't lived up to that hype, nor has it met the guidance that was provided....
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-11717
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$16.85 |
Change
-0.180(1.06%) |
Mkt cap ! $2.144B |
Open | High | Low | Value | Volume |
$16.94 | $17.02 | $16.59 | $4.083M | 242.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 404 | $16.83 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.85 | 127 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 191 | 16.820 |
5 | 373 | 16.810 |
9 | 829 | 16.800 |
7 | 1141 | 16.790 |
5 | 1236 | 16.780 |
Price($) | Vol. | No. |
---|---|---|
16.830 | 67 | 4 |
16.840 | 357 | 3 |
16.850 | 511 | 3 |
16.860 | 884 | 5 |
16.870 | 1174 | 5 |
Last trade - 12.45pm 13/11/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online